Literature DB >> 19439991

Henoch-Schönlein nephritis: a nationwide study.

O Soylemezoglu1, O Ozkaya, S Ozen, A Bakkaloglu, R Dusunsel, H Peru, A Cetinyurek, N Yildiz, O Donmez, N Buyan, S Mir, N Arisoy, A Gur-Guven, H Alpay, M Ekim, N Aksu, A Soylu, F Gok, H Poyrazoglu, F Sonmez.   

Abstract

BACKGROUND/AIM: The aim of this retrospective study was to evaluate the presentation, clinical and pathological manifestations and outcome of the Henoch-Schönlein purpura (HSP) nephritis in children.
METHODS: Clinical and laboratory data of 443 children with HSP nephritis aged between 3 and 16 years from 16 pediatric nephrology reference centers were analyzed retrospectively. The biopsy findings were graded according to the classification developed by the International Study of Kidney Disease in Children (ISKDC).
RESULTS: Renal biopsy was performed in 179 of the patients with HSP nephritis. The most common presenting clinical finding in patients who were biopsied was nephrotic range proteinuria (25%) which was followed by nephritic-nephrotic syndrome (23.5%). The biopsy findings according to the ISKDC were as follows: class I: 8.3%; II: 44.1%; III: 36.3%; IV: 6.7%; V: 3.3%; VI: 1.1%. All of the patients who developed end-stage renal disease had nephritic-nephrotic syndrome at presentation. Of 443 patients, 87.2% had a favorable outcome and 12.8% had an unfavorable outcome. The overall percentage of children who developed end-stage renal disease at follow-up was 1.1%. Logistic regression analysis did not show any association of initial symptoms and histology with outcome.
CONCLUSION: In the presented cohort, the presence of crescents in the first biopsy or presenting clinical findings did not seem to predict the outcome of HSP nephritis in children. We conclude that children with HSP nephritis even with isolated microscopic hematuria and/or mild proteinuria should be followed closely. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19439991     DOI: 10.1159/000218109

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  22 in total

1.  Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report.

Authors:  Erynn M Boyer; Martin Turman; Kathleen M O'Neil
Journal:  Pediatr Rheumatol Online J       Date:  2011-08-11       Impact factor: 3.054

2.  Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.

Authors:  Jean-Daniel Delbet; Guillaume Geslain; Martin Auger; Julien Hogan; Rémi Salomon; Michel Peuchmaur; Georges Deschênes; David Buob; Cyrielle Parmentier; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2019-11-06       Impact factor: 3.714

3.  Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis.

Authors:  Xiao-Qing Yang; Yan-Jie Huang; Wen-Sheng Zhai; Xian-Qing Ren; Qing-Yin Guo; Xia Zhang; Meng Yang; Jian Zhang; Ying Ding; Shan Zhu; Tatsuo Yamamoto; Yuan Sun
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

4.  Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?

Authors:  Adam Jimenez; Ashton Chen; Jen-Jar Lin; Andrew M South
Journal:  Pediatr Nephrol       Date:  2019-08-11       Impact factor: 3.714

5.  Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children.

Authors:  Yan-Jie Huang; Xiao-Qing Yang; Wen-Sheng Zhai; Xian-Qing Ren; Qing-Yin Guo; Xia Zhang; Meng Yang; Tatsuo Yamamoto; Yuan Sun; Ying Ding
Journal:  World J Pediatr       Date:  2014-11-20       Impact factor: 2.764

6.  Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.

Authors:  Jean Daniel Delbet; Julien Hogan; Bilal Aoun; Iulia Stoica; Rémi Salomon; Stéphane Decramer; Isabelle Brocheriou; Georges Deschênes; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2017-02-15       Impact factor: 3.714

7.  Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.

Authors:  Hikaru Sugimoto; Shiho Matsuno; Noriko Yamanaka; Wako Yumura; Mitsuyo Itabashi; Takashi Takei
Journal:  CEN Case Rep       Date:  2020-08-04

8.  The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Eichi Yugeta; Masahiko Katayose; Shigeo Suzuki; Hiroko Sakuma; Kenji Nemoto; Akira Tsukagoshi; Katsutoshi Nagasawa; Mitsuaki Hosoya
Journal:  Int Urol Nephrol       Date:  2010-01-10       Impact factor: 2.370

9.  Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.

Authors:  Izabel M Buscatti; Beatriz B Casella; Nadia E Aikawa; Andrea Watanabe; Sylvia C L Farhat; Lucia M A Campos; Clovis Artur Silva
Journal:  Clin Rheumatol       Date:  2018-01-13       Impact factor: 2.980

Review 10.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.